SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001447028-22-000051
Filing Date
2022-10-24
Accepted
2022-10-24 07:01:44
Documents
14
Period of Report
2022-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abus-20221018.htm   iXBRL 8-K 43347
2 EX-10.1 ex101-thirdamendmenttoexec.htm EX-10.1 13530
  Complete submission text file 0001447028-22-000051.txt   211220

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20221018.xsd EX-101.SCH 2150
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20221018_def.xml EX-101.DEF 2889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20221018_lab.xml EX-101.LAB 25876
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20221018_pre.xml EX-101.PRE 14136
8 EXTRACTED XBRL INSTANCE DOCUMENT abus-20221018_htm.xml XML 12773
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 221324819
SIC: 2834 Pharmaceutical Preparations